Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines

References

• Ahmed TA, Aljaeid BM. (2016). Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Design Dev Ther 10:483–507.
   PubMed Web of Science ®Google Scholar
• Almeida JPM, Lin AY, Figueroa ER, et al. (2015). In vivo gold nanoparticle delivery of peptide vaccine induces anti-tumor immune response in prophylactic and therapeutic tumor models. Small 11:1453–9.
   PubMed Web of Science ®Google Scholar
• Alsaleh NB, Persaud I, Brown JM. (2016). Silver nanoparticle-directed mast cell degranulation is mediated through calcium and PI3K signaling independent of the high affinity IgE receptor. PLoS One 11:e0167366.
   Web of Science ®Google Scholar
• Banskota S, Yousefpour P, Chilkoti A. (2017). Cell-based biohybrid drug delivery systems: the best of the synthetic and natural worlds. Macromol Biosci 17:1600361.
   PubMed Web of Science ®Google Scholar
• Barati N, Nikpoor AR, Razazan A, et al. (2017). Nanoliposomes carrying HER2/neu-derived peptide AE36 with CpG-ODN exhibit therapeutic and prophylactic activities in a mice TUBO model of breast cancer. Immunol Lett. 190:108–17.
   PubMed Web of Science ®Google Scholar
• Barbara R, Belletti D, Pederzoli F, et al. (2017). Novel curcumin loaded nanoparticles engineered for blood-brain barrier crossing and able to disrupt Abeta aggregates. Int J Pharm 526:413–24.
   PubMed Web of Science ®Google Scholar
• Bernocchi B, Carpentier R, Lantier I, et al. (2016). Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles. J Control Release 232:42–50.
   PubMed Web of Science ®Google Scholar
• Bharali DJ, Pradhan V, Elkin G, et al. (2008). Novel nanoparticles for the delivery of recombinant hepatitis B vaccine. Nanomedicine 4:311–17.
   PubMed Web of Science ®Google Scholar
• Bhargava A, Mishra D, Banerjee S, Mishra PK. (2013). Engineered dendritic cells for gastrointestinal tumor immunotherapy: opportunities in translational research. J Drug Target 21:126–36.
   PubMed Web of Science ®Google Scholar
• Bolhassani A, Safaiyan S, Rafati S. (2011). Improvement of different vaccine delivery systems for cancer therapy. Mol Cancer 10:3.
   PubMed Web of Science ®Google Scholar
• Burger C, Shahzad Y, Bruemmer A, et al. (2017). Traversing the skin barrier with nano-emulsions. Curr Drug Deliv 14:458–72.
   PubMed Web of Science ®Google Scholar
• Caballero I, Aira LE, Lavastida A, et al. (2017). Safety and immunogenicity of a human epidermal growth factor receptor 1 (HER1)-based vaccine in prostate castration-resistant carcinoma patients: a dose-escalation phase I study trial. Front Pharmacol 8:263.
   PubMed Web of Science ®Google Scholar
• Chiang C-H, Hosseinkhani H, Cheng W-S, et al. (2013). Improving drug loading efficiency and delivery performance of micro- and nanoparticle preparations through optimising formulation variables. Int J Environ Res 10:996–1006.
   Google Scholar
• Conniot J, Silva JM, Fernandes JG, et al. (2014). Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking. Front Chem 2:105.
   PubMed Web of Science ®Google Scholar
• Damge C, Maincent P, Ubrich N. (2007). Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Release 117:163–70.
   PubMed Web of Science ®Google Scholar
• Darban SA, Badiee A, Jaafari MR. (2017). PNC27 anticancer peptide as targeting ligand significantly improved antitumor efficacy of Doxil in HDM2-expressing cells. Nanomedicine 12:1475–90.
   PubMed Web of Science ®Google Scholar
• Delie F, Allemann E, Cohen M. (2012). Nanocarriers for ovarian cancer active drug targeting. J Drug Deliv Sci Technol 22:421–6.
   Web of Science ®Google Scholar
• DeLong RK, Akhtar U, Sallee M, et al. (2009). Characterization and performance of nucleic acid nanoparticles combined with protamine and gold. Biomaterials 30:6451–9.
   PubMed Web of Science ®Google Scholar
• Dinda SC, Pattnaik G. (2013). Nanobiotechnology-based drug delivery in brain targeting. Curr Pharm Biotechnol 14:1264–74.
   PubMed Web of Science ®Google Scholar
• Draz MS, Wang Y-J, Chen FF, et al. (2017). Electrically oscillating plasmonic nanoparticles for enhanced DNA vaccination against hepatitis C virus. Adv Funct Mater 27:pii:1604139.
   PubMed Web of Science ®Google Scholar
• Fang RH, Hu C-MJ, Luk BT, et al. (2014). Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett 14:2181–8.
   PubMed Web of Science ®Google Scholar
• El-Say KM, El-Sawy HS. (2017). Polymeric nanoparticles: promising platform for drug delivery. Int J Pharm 528:675–91.
   PubMed Web of Science ®Google Scholar
• Friede M, Aguado MT. (2005). Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems. Adv Drug Deliv Rev 57:325–31.
   PubMed Web of Science ®Google Scholar
• Fytianos K, Rodriguez-Lorenzo L, Clift MJD, et al. (2015). Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Nanomed Nanotechnol Biol Med 11:633–44.
   PubMed Web of Science ®Google Scholar
• Gato WE, Hunter DA, Byrd IC, et al. (2017). Assessment of the short-term toxicity of TiO2 nanofiber in Sprague Dawley rats. Environ Toxicol 32:1775–83.
   PubMed Web of Science ®Google Scholar
• Ge W, Li Y, Li Z-S, et al. (2009). The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route. Cancer Immunol Immunother 58:201–8.
   PubMed Web of Science ®Google Scholar
• Ge W, Sui YF, Wu DC, et al. (2006). MAGE-1/Heat shock protein 70/MAGE-3 fusion protein vaccine in nanoemulsion enhances cellular and humoral immune responses to MAGE-1 or MAGE-3 in vivo. Cancer Immunol Immunother 55:841–9.
   PubMed Web of Science ®Google Scholar
• Gomes AJ, Lunardi LO, Marchetti JM, et al. (2005). Photobiological and ultrastructural studies of nanoparticles of poly(lactic-co-glycolic acid)-containing bacteriochlorophyll-a as a photosensitizer useful for PDT treatment. Drug Deliv 12:159–64.
   PubMed Web of Science ®Google Scholar
• Gong J, Chen M, Zheng Y, et al. (2012). Polymeric micelles drug delivery system in oncology. J Control Release 159:312–23.
   PubMed Web of Science ®Google Scholar
• Gupta R, Rai B. (2017). Effect of size and surface charge of gold nanoparticles on their skin permeability: a molecular dynamics study. Sci Rep 7:45292.
   Web of Science ®Google Scholar
• Hainfeld JF, Dilmanian FA, Zhong Z, et al. (2010). Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys Med Biol 55:3045–59.
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, O’Connor MJ, Lin P, et al. (2014). Infrared-transparent gold nanoparticles converted by tumors to infrared absorbers cure tumors in mice by photothermal therapy. PLoS One 9:e88414.
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Slatkin DN, Smilowitz HM. (2004). The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 49:N309–15.
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Smilowitz HM, O’Connor MJ, et al. (2013). Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine 8:1601–9.
   PubMed Web of Science ®Google Scholar
• Harms M, Mueller-Goymann CC. (2011). Solid lipid nanoparticles for drug delivery. J Drug Deliv Sci Technol 21:89–99.
   Web of Science ®Google Scholar
• Hsieh HH, Ho LC, Chang HT. (2016). Aminophenylboronic acid polymer nanoparticles for quantitation of glucose and for insulin release. Anal Bioanal Chem 408:6557–65.
   PubMed Web of Science ®Google Scholar
• Hu Y, Hoerle R, Ehrich M, Zhang C. (2015). Engineering the lipid layer of lipid-PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability. Acta Biomater 28:149–59.
   PubMed Web of Science ®Google Scholar
• Huo M, Zhao Y, Satterlee AB, et al. (2017). Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment. J Control Release 245:81–94.
   PubMed Web of Science ®Google Scholar
• Jain A, Cheng K. (2017). The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis. J Control Release 245:27–40.
   PubMed Web of Science ®Google Scholar
• Jalali SA, Sankian M, Tavakkol-Afshari J, Jaafari MR. (2012). Induction of tumor-specific immunity by multi-epitope rat HER2/neu-derived peptides encapsulated in LPD Nanoparticles. Nanomedicine 8:692–701.
   PubMed Web of Science ®Google Scholar
• Ji Z, Xie Z, Zhang Z, et al. (2017). Engineering intravaginal vaccines to overcome mucosal and epithelial barriers. Biomaterials 128:8–18.
   PubMed Web of Science ®Google Scholar
• Jia F, Liu X, Li L, et al. (2013). Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents. J Control Release 172:1020–34.
   PubMed Web of Science ®Google Scholar
• Kim SY, Noh YW, Kang TH, et al. (2017). Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity. Biomaterials 130:56–66.
   PubMed Web of Science ®Google Scholar
• Klippstein R, Pozo D. (2010). Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies. Nanomed Nanotechnol Biol Med 6:523–9.
   PubMed Web of Science ®Google Scholar
• Kogan MJ, Olmedo I, Hosta L, et al. (2007). Peptides and metallic nanoparticles for biomedical applications. Nanomedicine 2:287–306.
   PubMed Web of Science ®Google Scholar
• Kotla NG, Chandrasekar B, Rooney P, et al. (2017). Biomimetic lipid-based nanosystems for enhanced dermal delivery of drugs and bioactive agents. Acs Biomater Sci Eng 3:1262–72.
   PubMed Web of Science ®Google Scholar
• Kreuter J. (2005). Application of nanoparticles for the delivery of drugs to the brain. In: DeBoer AG, editor. Drug transport(ers) and the diseased brain. Elsevier: Amsterdam, 85–94.
   Google Scholar
• Kreuter J. (2012). Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 64:213–22.
   Web of Science ®Google Scholar
• Kroll AV, Fang RH, Zhang L. (2017). Biointerfacing and applications of cell membrane-coated nanoparticles. Bioconjug Chem 28:23–32.
   PubMed Web of Science ®Google Scholar
• Labhasetwar V, Song C, Humphrey W, et al. (1998). Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J Pharm Sci 87:1229–34.
   PubMed Web of Science ®Google Scholar
• Lai SK, Wang Y-Y, Hanes J. (2009). Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 61:158–71.
   PubMed Web of Science ®Google Scholar
• Le Boeuf F, Selman M, Son HH, et al. (2017). Oncolytic maraba virus MG1 as a treatment for sarcoma. Int J Cancer 141:1257–64.
   PubMed Web of Science ®Google Scholar
• Li C, Liang S, Zhang C, et al. (2015). Allogenic dendritic cell and tumor cell fused vaccine for targeted imaging and enhanced immunotherapeutic efficacy of gastric cancer. Biomaterials 54:177–87.
   PubMed Web of Science ®Google Scholar
• Li H, Li Y, Jiao J, Hu H-M. (2011). Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response. Nat Nanotechnol 6:645–50.
   PubMed Web of Science ®Google Scholar
• Lin AY, Lunsford J, Bear AS, et al. (2013). High-density sub-100-nm peptide-gold nanoparticle complexes improve vaccine presentation by dendritic cells in vitro. Nanoscale Res Lett 8:72.
   Web of Science ®Google Scholar
• Liu J, Yang Y, Zhu W, et al. (2016). Nanoscale metal-organic frameworks for combined photodynamic & radiation therapy in cancer treatment. Biomaterials 97:1–9.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen C. (2016). Role of nanotechnology in HIV/AIDS vaccine development. Adv Drug Deliv Rev 103:76–89.
   PubMed Web of Science ®Google Scholar
• Luo M, Wang H, Wang Z, et al. (2017). A STING-activating nanovaccine for cancer immunotherapy. Nat Nanotechnol 12:648+.
   PubMed Web of Science ®Google Scholar
• Luo Z, Wang C, Yi H, et al. (2015). Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo. Biomaterials 38:50–60.
   PubMed Web of Science ®Google Scholar
• Mahapatro A, Singh DK. (2011). Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnol 9:55.
   PubMed Web of Science ®Google Scholar
• Mansourian M, Badiee A, Jalali SA, et al. (2014). Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN. Immunol Lett 162(Pt A):87–93.
   PubMed Web of Science ®Google Scholar
• Marquardt C, Fritsch-Decker S, Al-Rawi M, et al. (2017). Autophagy induced by silica nanoparticles protects RAW264.7 macrophages from cell death. Toxicology 379:40–7.
   PubMed Web of Science ®Google Scholar
• Melero I, Berman DM, Angela Aznar M, et al. (2015). Evolving synergistic combinations of targeted immunotherapies to combat cancer. Nat Rev Cancer 15:457–72.
   PubMed Web of Science ®Google Scholar
• Miyabe H, Hyodo M, Nakamura T, et al. (2014). A new adjuvant delivery system ‘cyclic di-GMP/YSK05 liposome’ for cancer immunotherapy. J Control Release 184:20–7.
   PubMed Web of Science ®Google Scholar
• Mocan T, Matea C, Tabaran F, et al. (2015). In vitro administration of gold nanoparticles functionalized with MUC-1 protein fragment generates anticancer vaccine response via macrophage activation and polarization mechanism. J Cancer 6:583–92.
   PubMed Web of Science ®Google Scholar
• Morera Y, Sanchez J, Bequet-Romero M, et al. (2017). Specific humoral and cellular immune responses in cancer patients undergoing chronic immunization with a VEGF-based therapeutic vaccine. Vaccine 35:3582–90.
   PubMed Web of Science ®Google Scholar
• Neamtu I, Rusu AG, Diaconu A, et al. (2017). Basic concepts and recent advances in nanogels as carriers for medical applications. Drug Deliv 24:539–57.
   PubMed Web of Science ®Google Scholar
• Nicol JR, Dixon D, Coulter JA. (2015). Gold nanoparticle surface functionalization: a necessary requirement in the development of novel nanotherapeutics. Nanomedicine 10:1315–26.
   PubMed Web of Science ®Google Scholar
• Nikpoor AR, Tavakkol-Afshari J, Sadri K, et al. (2017). Improved tumor accumulation and therapeutic efficacy of CTLA-4-blocking antibody using liposome-encapsulated antibody: in vitro and in vivo studies. Nanomed Nanotechnol Biol Med 13:2671–82.
   PubMed Web of Science ®Google Scholar
• Niu Z, Conejos-Sanchez I, Griffin BT, et al. (2016). Lipid-based nanocarriers for oral peptide delivery. Adv Drug Deliv Rev 106:337–54.
   PubMed Web of Science ®Google Scholar
• Noble GT, Stefanick JF, Ashley JD, et al. (2014). Ligand-targeted liposome design: challenges and fundamental considerations. Trends Biotechnol 32:32–45.
   PubMed Web of Science ®Google Scholar
• Orunoglu M, Kaffashi A, Pehlivan SB, et al. (2017). Effects of curcumin-loaded PLGA nanoparticles on the RG2 rat glioma model. Mater Sci Eng C Mater Biol Appl 78:32–8.
   PubMed Web of Science ®Google Scholar
• Popov A, Enlow E, Bourassa J, Chen H. (2016). Mucus-penetrating nanoparticles made with “mucoadhesive” poly(vinyl alcohol). Nanomed Nanotechnol Biol Med 12:1863–71.
   PubMed Web of Science ®Google Scholar
• Prasad S, Cody V, Saucier-Sawyer JK, et al. (2011). Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy. Nanomed Nanotechnol Biol Med 7:1–10.
   PubMed Web of Science ®Google Scholar
• Pushpalatha R, Selvamuthukumar S, Kilimozhi D. (2017). Nanocarrier mediated combination drug delivery for chemotherapy - a review. J Drug Deliv Sci Technol 39:362–71.
   Web of Science ®Google Scholar
• Qidwai A, Khan S, Md S, et al. (2016). Nanostructured lipid carrier in photodynamic therapy for the treatment of basal-cell carcinoma. Drug Deliv 23:1476–85.
   PubMed Web of Science ®Google Scholar
• Rahimian S, Fransen MF, Kleinovink JW, et al. (2015). Particulate systems based on poly(lactic-co-glycolic)acid (pLGA) for immunotherapy of cancer. Curr Pharm Des 21:4201–16.
   PubMed Web of Science ®Google Scholar
• Sen K, Mandal M. (2013). Second generation liposomal cancer therapeutics: transition from laboratory to clinic. Int J Pharm 448:28–43.
   PubMed Web of Science ®Google Scholar
• Shariat S, Badiee A, Jalali SA, et al. (2014). P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer. Cancer Lett 355:54–60.
   PubMed Web of Science ®Google Scholar
• Shi Q, Tao Z, Yang H, et al. (2017). PDGFRβ-specific affibody-directed delivery of a photosensitizer, IR700, is efficient for vascular-targeted photodynamic therapy of colorectal cancer. Drug Deliv 24:1818–30.
   PubMed Web of Science ®Google Scholar
• Shimoni O, Postma A, Yan Y, et al. (2012). Macromolecule functionalization of disulfide-bonded polymer hydrogel capsules and cancer cell targeting. ACS Nano 6:1463–72.
   PubMed Web of Science ®Google Scholar
• Siefert AL, Ehrlich A, Corral MJ, et al. (2016). Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse model. Biomaterials 108:168–76.
   PubMed Web of Science ®Google Scholar
• Singh A, Peppas NA. (2014). Hydrogels and scaffolds for immunomodulation. Adv Mater Weinheim 26:6530–41.
   PubMed Web of Science ®Google Scholar
• Sun B, Xia T. (2016). Nanomaterial-based vaccine adjuvants. J Mater Chem B 4:5496–509.
   PubMed Web of Science ®Google Scholar
• Toyoda M, Hama S, Ikeda Y, et al. (2015). Anti-cancer vaccination by transdermal delivery of antigen peptide-loaded nanogels via iontophoresis. Int J Pharm 483:110–14.
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Hola K, Subr V, et al. (2016). Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies. Chem Rev 116:5338–431.
   PubMed Web of Science ®Google Scholar
• Valente F, Astolfi L, Simoni E, et al. (2017). Nanoparticle drug delivery systems for inner ear therapy: an overview. J Drug Deliv Sci Technol 39:28–35.
   Web of Science ®Google Scholar
• Vangasseri DP, Cui Z, Chen W, et al. (2006). Immunostimulation of dendritic cells by cationic liposomes. Mol Membr Biol 23:385–95.
   PubMed Web of Science ®Google Scholar
• van der Meel R, Fens MHAM Vader P, et al. (2014). Extracellular vesicles as drug delivery systems: lessons from the liposome field. J Control Release 195:72–85.
   PubMed Web of Science ®Google Scholar
• Vonderheide RH, Domchek SM, Clark AS. (2017). Immunotherapy for breast cancer: what are we missing? Clin Cancer Res. 23:2640–6.
   PubMed Web of Science ®Google Scholar
• Wang C, Li P, Liu L, et al. (2016). Self-adjuvanted nanovaccine for cancer immunotherapy: role of lysosomal rupture-induced ROS in MHC class I antigen presentation. Biomaterials 79:88–100.
   PubMed Web of Science ®Google Scholar
• Wang X, Yang D, Li S, et al. (2016). Biomineralized vaccine nanohybrid for needle-free intranasal immunization. Biomaterials 106:286–94.
   PubMed Web of Science ®Google Scholar
• Xu Y, Deng L, Ren H, et al. (2017). Transport of nanoparticles across pulmonary surfactant monolayer: a molecular dynamics study. Phys Chem Chem Phys 19:17568–76.
   PubMed Web of Science ®Google Scholar
• Yazdani M, Jalali SA, Badiee A, et al. (2017). Stimulation of tumor-specific immunity by p5 HER-2/neu generated peptide encapsulated in nano-liposomes with high phase transition temperature phospholipids. Curr Drug Deliv 14:492–502.
   PubMed Web of Science ®Google Scholar
• Yue H, Wei W, Gu Z, et al. (2015). Exploration of graphene oxide as an intelligent platform for cancer vaccines. Nanoscale 7:19949–57.
   PubMed Web of Science ®Google Scholar
• Zeng Q, Li H, Jiang H, et al. (2017). Tailoring polymeric hybrid micelles with lymph node targeting ability to improve the potency of cancer vaccines. Biomaterials 122:105–13.
   PubMed Web of Science ®Google Scholar
• Zhang X. (2015). Gold nanoparticles: recent advances in the biomedical applications. Cell Biochem Biophys 72:771–5.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Meng F, Deng C, Zhong Z. (2014). Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy. Biomacromolecules 15:1955–69.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Wu SD, Wu SS, et al. (2017). Biodegradable nano-hybrid vehicles for combinatorial and targeted drug delivery for glioma treatment. J Biomater Tissue Eng 7:363–70.
   Web of Science ®Google Scholar
• Zikry J, Korta DZ, Chapman LW, Linden KG. 2017. Melanoma arising in an ovarian cystic teratoma: a systematic review of presentation, treatment, and outcomes. Arch Gynecol Obstet 296:397–404.
   PubMed Web of Science ®Google Scholar